Market closed
Cyclerion Therapeutics Inc./$CYCN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Ticker
$CYCN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
1
Website
CYCN Metrics
BasicAdvanced
$7.3M
-
-$1.21
2.09
-
Price and volume
Market cap
$7.3M
Beta
2.09
52-week high
$2.99
52-week low
$2.28
Average daily volume
28K
Financial strength
Current ratio
5.828
Quick ratio
5.225
Management effectiveness
Return on assets (TTM)
-19.76%
Return on equity (TTM)
-30.36%
Valuation
Price to revenue (TTM)
3.588
Price to book
0.82
Price to tangible book (TTM)
0.82
Price to free cash flow (TTM)
-1.656
Growth
Earnings per share change (TTM)
-46.07%
3-year revenue growth (CAGR)
-20.24%
3-year earnings per share growth (CAGR)
-64.17%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Cyclerion Therapeutics Inc. stock?
Cyclerion Therapeutics Inc. (CYCN) has a market cap of $7.3M as of April 16, 2025.
What is the P/E ratio for Cyclerion Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Cyclerion Therapeutics Inc. (CYCN) stock is 0 as of April 16, 2025.
Does Cyclerion Therapeutics Inc. stock pay dividends?
No, Cyclerion Therapeutics Inc. (CYCN) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Cyclerion Therapeutics Inc. dividend payment date?
Cyclerion Therapeutics Inc. (CYCN) stock does not pay dividends to its shareholders.
What is the beta indicator for Cyclerion Therapeutics Inc.?
Cyclerion Therapeutics Inc. (CYCN) has a beta rating of 2.09. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.